UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Link to "El español"
Link to "Apunt" Video
Link to "Innospain"
Link to "La Sexta"
Link to "Cadena Ser"
Link to "News Medical"

Related posts
Bridging Academia and Industry: The Strategic Role of Corify’s PhD Industrial Researchers

At Corify Care, research is not just a phase; it is the foundation of our technology. We are proud to highlight the...

Read More »
Corify Strengthens Its Commitment to Science and Talent Through the Torres Quevedo Program

Corify Strengthens Its Commitment to Science and Talent Through the Torres Quevedo Program Corify Care continues to reinforce its long-term commitment to...

Read More »
Hospital Gregorio Marañón Launches Pioneering Clinical Trial for Complex AF Using Novel Corify-Guided Ablation Strategy

The Hospital Gregorio Marañón, a world-renowned leader in cardiology, has launched a new prospective clinical trial to tackle one of the toughest...

Read More »